The subsidiary VUM02 injection clinical trial application of Venues Health (600645.SH) has obtained the acceptance notice.

Tencent Finance APP News, Zhongyuan Xiehe (600645.SH) announced that its wholly-owned subsidiary Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd. obtained the "Acceptance Notice" for the clinical trial application for VUM02 injection issued by the Drug Evaluation Center (CDE) of the National Medical Products Administration on August 1, 2025. The acceptance number is CXSL2500651.